Seeking Alpha

More on Amgen (AMGN): Q1 beats across the board on strong sales growth and better margins....

More on Amgen (AMGN): Q1 beats across the board on strong sales growth and better margins. Combined sales of Neulasta and Neupogen +9%, Xgeva +14%, and Prolia +9%. Operating margins rose to 36.4% from 34.9%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)